Activation of the PI3K–AKT–mTOR signaling pathway promotes DEHP-induced Hep3B cell proliferation
Authors:
- Qizhi QinQQQizhi Qin
- Wenjuan ZhangWZWenjuan Zhang
- Youjian ZhangYZYoujian Zhang
- Hongyan ZhengHZHongyan Zheng
- Chuanyao LiuCLChuanyao Liu
- Yuqing YangYYYuqing Yang
- Wei XiongWXWei Xiong
- Jing YuanJYJing Yuan
- 1 September 2013
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 59, 325-333
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30972437)
- National Basic Research Program of China (2011CB512102)
This publication has 51 references indexed in Scilit:
- DEHP: Genotoxicity and potential carcinogenic mechanisms—A reviewMutation Research - Reviews in Mutation Research, 2012
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human HealthOncotarget, 2011
- Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell deathFree Radical Biology and Medicine, 2011
- Targeting the PI3K/mTOR Pathway in Murine Endocrine Cell LinesThe American Journal of Pathology, 2011
- Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK SignalingPLOS ONE, 2010
- Organophosphate and phthalate esters in air and settled dust - a multi-location indoor studyIndoor Air, 2010
- Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectorsEndocrine-Related Cancer, 2009
- The importance of redox state in liver damageAnnals of Hepatology, 2004
- The tor pathway: a target for cancer therapyNature Reviews Cancer, 2004
- Oxidative DNA damage: mechanisms, mutation, and diseaseThe FASEB Journal, 2003